Investing

First Look Analysts Research Calls for Friday, February 3

Mario Tama / Getty Images News via Getty Images

This report was sent to Briefing.com subscribers earlier today. 

Upgrades:

> Cardinal Health (CAH) upgraded to Outperform from Neutral at Robert W. Baird; tgt raised to $94

> H.B. Fuller (FUL) upgraded to Buy from Neutral at Citigroup; tgt raised to $85

> Int’l Paper (IP) upgraded to Neutral from Sell at UBS; tgt raised to $43

> Nordstrom (JWN) upgraded to Hold from Reduce at Gordon Haskett; tgt $22

Downgrades:

> Aptiv (APTV) downgraded to Peer Perform from Outperform at Wolfe Research

> Boeing (BA) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt $225

> C.H. Robinson (CHRW) downgraded to Hold from Buy at Stifel; tgt lowered to $99

> Camden Property (CPT) downgraded to Neutral from Overweight at Piper Sandler; tgt $136

> Cognizant Tech (CTSH) downgraded to Neutral from Outperform at Robert W. Baird; tgt raised to $68

> First Foundation (FFWM) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $16

> Focus Financial (FOCS) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt lowered to $53

> Ford Motor (F) downgraded to Sell from Hold at Deutsche Bank; tgt lowered to $11

> Generac (GNRC) downgraded to Neutral from Buy at Guggenheim

> Hexcel (HXL) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $70

> Hilton Grand Vacations (HGV) downgraded to Hold from Buy at Jefferies; tgt lowered to $52

> Spirit Aerosystems (SPR) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $36

> Travel + Leisure Co (TNL) downgraded to Hold from Buy at Jefferies; tgt lowered to $49

Others:

> Agios Pharma (AGIO) initiated with an Overweight at Piper Sandler; tgt $41

> Day One Biopharmaceuticals (DAWN) initiated with a Perform at Oppenheimer

> Herbalife Nutrition (HLF) initiated with an Underperform at BofA Securities; tgt $14

> Privia Health (PRVA) initiated with a Buy at Goldman; tgt $32

> Relay Therapeutics (RLAY) initiated with an Outperform at Oppenheimer; tgt $33

> Tyra Biosciences (TYRA) initiated with an Outperform at Oppenheimer; tgt $17

Sponsored: Attention Savvy Investors: Speak to 3 Financial Experts – FREE

Ever wanted an extra set of eyes on an investment you’re considering? Now you can speak with up to 3 financial experts in your area for FREE. By simply
clicking here
you can begin to match with financial professionals who can help guide you through the financial decisions you’re making. And the best part? The first conversation with them is free.


Click here
to match with up to 3 financial pros who would be excited to help you make financial decisions.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.